Human 5′ UTR design and variant effect prediction from a massively parallel translation assay
Open accessPublished version of a preprint
Abstract
The ability to predict the impact of cis-regulatory sequences on gene expression would facilitate discovery in fundamental and applied biology. Here we combine polysome profiling of a library of 280,000 randomized 5' untranslated regions (UTRs) with deep learning to build a predictive model that relates human 5' UTR sequence to translation. Together with a genetic algorithm, we use the model to engineer new 5' UTRs that accurately direct specified levels of ribosome loading, providing the ability to tune sequences for optimal protein expression. We show that the same approach can be extended to chemically modified RNA, an important feature for applications in mRNA therapeutics and synthetic biology. We test 35,212 truncated human 5' UTRs and 3,577 naturally occurring variants and show that the model predicts ribosome loading of these sequences. Finally, we provide evidence of 45 single-nucleotide variants (SNVs) associated with human diseases that substantially change ribosome loading and thus may represent a molecular basis for disease.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper combines polysome profiling of a 280,000-member randomized human 5′ UTR library with a convolutional neural network, Optimus 5-Prime, to predict ribosome loading from 5′ UTR sequence. The model explains up to 93% of mean ribosome load variation, predicts effects of human variants and modified RNA, and enables genetic-algorithm design of 5′ UTRs for targeted translation.
Key findings
- Optimus 5-Prime explained 93% of MRL variation in a held-out test set of 20,000 sequences, versus at best 66% for position-specific k-mer linear models; it also predicted full polysome distributions with an average 83% of variation across fractions.
- The model generalized to an mCherry reporter library (77% and 78% of MRL variation in two experiments), to 35,212 common human 5′ UTRs plus 3,577 ClinVar variants (81% of MRL variation), and to Ψ- and m1Ψ-modified RNA (68% and 76% of variability, respectively).
- For human variant effects, the model explained 55% of observed MRL change and predicted direction for 64% of variants; 45 SNVs had log2 differences >0.5 or <−0.5, including CPOX rs867711777 (−0.89), RPL5 rs376208311 (−0.87), and TMEM127 rs121908813 (−1.5).
- A genetic algorithm designed 12,000 UTRs for target MRLs; after retraining on 6,082 target-MRL UTRs and 2,695 unseen random UTRs, held-out target-MRL performance improved from r² = 0.386 to 0.772.
Methods
- A 280,000-member eGFP library with 50-nt random 5′ UTRs was in vitro transcribed, transfected into HEK293T cells, polysome-profiled, sequenced, and converted to mean ribosome load (MRL); validation included mCherry, modified UTP, human/ClinVar, and 25–100 nt length libraries.
- A CNN was trained on 260,000 sequences and tested on 20,000, using Keras/TensorFlow, grid-search hyperparameters, three convolution layers, and a dense layer; separate models predicted polysome fractions and were used with a genetic algorithm for UTR design.
- Human analyses used the first 50 nt upstream of annotated translation initiation sites for 35,212 Ensembl transcripts and 3,577 ClinVar variants; a generalized model used 76,319 random sequences of 25–100 nt and test sets of 7,600 random and 7,600 human UTRs.
Limitations
- The paper states that the model was trained on synthetic random sequences, that the 50-nt model covers only 13% of human 5′ UTRs, that the 25–100 nt extension covers 29%, and that longer UTRs had lower read coverage and lower test-set quality.
- The paper notes lower accuracy for variant effect prediction because it compares two noisy measurements and most variants have little effect; it also reports divergence at very high MRLs due to unusual poly-U composition, corrected by retraining, and lower mCherry accuracy partly due to protocol differences.
- Evident from the text: experiments use HEK293T/HEK293 cells, transfected IVT mRNA, and eGFP/mCherry reporters rather than endogenous chromatin/transcription contexts; polysome profiling measures ribosome loading, with protein output validated only for selected UTRs, and the model does not include 5′ cap structure or 3′ UTR sequence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
24 of 51 cited sources checked · 9 supported · 1 flagged · accuracy not yet measured
- Premisecitation
A fully rational approach to designing functional 5′ UTRs has not yet been implemented.
“While there has been some success in this effort in prokaryotes, yeast and even mammalian cells27,34–36, a fully rational approach to designing functional 5′ UTRs has not yet been implemented.”
Quote in the paperSubstantial claim4 of 4 sources checked- cites [27] Ferreira, J. P., Overton, K. W. & Wang, C. L. Tuning gene expression with synthetic upstream open reading frames. Proc. Natl Acad. Sci. USA 110, 11284–11289 (2013). source
The opening discussion says there were few systematic approaches for precisely controlling recombinant-protein translation in mammalian cells, which supports the claim’s general concern about design methods. It does not say that a fully rational approach to designing functional 5′ UTRs had never been implemented; the Discussion instead describes the authors’ own systematic approach using engineered RNA leaders. The claim is broader than the source supports. (LLM, conf=0.80)
Experimental — accuracy not yet measured - cites [34] Seo, S. W. et al. Predictive design of mRNA translation initiation region to control prokaryotic translation efficiency. Metab. Eng. 15, 67–74 (2013). source
- cites [35] Jensen, M. K. & Keasling, J. D. Recent applications of synthetic biology tools for yeast metabolic engineering. FEMS Yeast Res. 15, 1–10 (2015). source
The editorial’s section “Yeast synthetic biology: new tools to unlock cellular function” discusses advances in synthetic-part design, but does not address 5′ UTRs or whether a fully rational approach to designing them has been implemented. Searches for 5′ UTR design and the claimed limitation found no passage that settles it; the copy has no page numbers. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [36] Salis, H. M., Mirsky, E. A. & Voigt, C. A. Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27, 946–950 (2009). source
The Materials and Methods section (Software Implementation; page unavailable) says the authors implemented an RBS Calculator that optimizes ribosome-binding-site sequences to rationally control protein expression. This contradicts the unqualified assertion that a rational design approach had not been implemented, although the paper addresses bacterial ribosome-binding sites rather than every feature of a 5′ UTR. (LLM, conf=0.77)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
Only 13% of human 5′ UTRs are shorter than 50 nt and thus covered by Optimus 5-Prime.
“Because only 13% of human 5′ UTRs are shorter than 50 nt and thus covered by Optimus 5-Prime, we next asked whether the approach introduced here could be extended to longer 5′ UTRs.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [44] Mignone, F. et al. Untranslated regions of mRNAs. Genome Biol. 3, reviews0004.1 (2002). source
The Structural features of untranslated regions section (page not available) says 5′ UTRs average 100–200 nucleotides and vary widely in length. It does not give the proportion of human 5′ UTRs shorter than 50 nucleotides or discuss coverage by Optimus 5-Prime. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [45] Leppek, K., Das, R. & Barna, M. Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell Biol. 19, 158–174 (2018). source
The section ‘5′ UTRs as platforms for RNA structure’ (page unavailable) reports a median human 5′ UTR length of 218 nucleotides, supporting the general point that many are longer than 50 nt. It does not give the 13% figure or discuss which UTRs Optimus 5-Prime covers. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Earlier MPRAs designed to learn aspects of 5′ UTR cis-regulation relied on FACS or growth selection to stratify libraries by activity.
“Earlier MPRAs designed to learn aspects of 5′ UTR cis-regulation relied on FACS10,11 or growth selection12 to stratify libraries by activity.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [10] Noderer, W. L. et al. Quantitative analysis of mammalian translation initiation sites by FACS-seq. Mol. Syst. Biol. 10, 748 (2014). source
- cites [11] Kosuri, S. et al. Composability of regulatory sequences controlling transcription and translation in Escherichia coli. Proc. Natl Acad. Sci. USA 110, 14024–14029 (2013). source
- cites [12] Cuperus, J. T. et al. Deep learning of the regulatory grammar of yeast 5′ untranslated regions from 500,000 random sequences. Genome Res. 27, 2015–2024 (2017). source
- Premisecitation
Translation initiation is largely dependent on start codons and their context and position relative to a CDS.
“Translation initiation is largely dependent on start codons and their context and position relative to a CDS12,17.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [12] Cuperus, J. T. et al. Deep learning of the regulatory grammar of yeast 5′ untranslated regions from 500,000 random sequences. Genome Res. 27, 2015–2024 (2017). source
- cites [17] Hinnebusch, A. G., Ivanov, I. P. & Sonenberg, N. Translational control by 5′-untranslated regions of eukaryotic mRNAs. Science 352, 1413–1416 (2016). source
- Premisecitation
The sequence of the 5′ untranslated region (5′ UTR) is a primary determinant of translation efficiency.
“The sequence of the 5′ untranslated region (5′ UTR) is a primary determinant of translation efficiency1,2.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [1] Araujo, P. R. et al. Before it gets started: regulating translation at the 5′ UTR. Comp. Funct. Genom. 2012, 475731 (2012). source
- cites [2] Jackson, R. J., Hellen, C. U. T. & Pestova, T. V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113–127 (2010). source
- Interpretationcitation
The improvement in prediction accuracy from training on modified RNAs is likely due to the model learning the impact of Ψ and m1Ψ on the formation of secondary structure.
“This is likely due to the model learning the impact of Ψ and m1Ψ on the formation of secondary structure33.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Kierzek, E. et al. The contribution of pseudouridine to stabilities and structure of RNAs. Nucleic Acids Res. 42, 3492–3501 (2014). source
The Results section reports that replacing U with Ψ usually increases RNA-duplex stability, supporting the premise that Ψ can affect RNA structure. The paper does not establish an effect of m1Ψ or examine whether a model learned either modification’s effects, so it cannot substantiate the proposed explanation for improved prediction accuracy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingown data
The paper's data captured and quantitated the repressive effect of secondary structure on ribosome load.
“By calculating UTR minimum free energies (MFE)26 and comparing them to UTR MRLs, we captured and quantitated this repressive effect of secondary structure on ribosome load (Supplementary Fig. 2c)17,25.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [26] Zadeh, J. N. et al. NUPACK: analysis and design of nucleic acid systems. J. Comput. Chem. 32, 170–173 (2011). source
- cites [17] Hinnebusch, A. G., Ivanov, I. P. & Sonenberg, N. Translational control by 5′-untranslated regions of eukaryotic mRNAs. Science 352, 1413–1416 (2016). source
- cites [25] Kozak, M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl Acad. Sci. USA 83, 2850–2854 (1986). source
The paper reports that highly stable 5′-UTR hairpins inhibit translation by 85–95%, supporting a repressive effect of secondary structure under those conditions. It does not report quantifying ribosome load; the Discussion instead distinguishes inhibition of translation from initial 40S-subunit binding. The citing authors’ calculation of MFE and comparison with ribosome load are their own analysis, not a measurement in this source. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
The model trained on the unmodified (U) library could explain 68% to 76% of the measured variability in the Ψ and m1Ψ polysome profiling data, respectively.
“We applied our method to transcripts bearing either Ψ and m1Ψ instead of uridine (U) (Fig. 2g) and found that the model trained on the unmodified (U) library could explain 68% to 76% of the measured variability in the Ψ and m1Ψ polysome profiling data, respectively (Fig. 2h).”
Quote in the paperSubstantial claim - Findingown data
For the three examples, the model predicts that, of all possible variants, these specific SNVs, all of which introduce an upstream start codon, would most dramatically affect ribosome loading.
“For the three examples, the model predicts that, of all possible variants, these specific SNVs, all of which introduce an upstream start codon, would most dramatically affect ribosome loading (Fig. 4c).”
Quote in the paperNot a substantial claim - Findingown data
The model captured the relationship between 5′ UTR sequence and distribution of ribosome occupancy on held out test data, explaining an average of 83% of variation across all fractions.
“Using a similar network architecture but with 14 linear outputs representing the polysome fractions (Supplementary Fig. 8), the model captured the relationship between 5′ UTR sequence and distribution of ribosome occupancy on held out test data remarkably well (Fig. 2c), explaining an average of 83% of variation across all fractions (Fig. 2d).”
Quote in the paperSubstantial claim - Findingown data
After polysome profiling and RNA sequencing, we retained 83,919 distinct 5′ UTRs spanning the entire length distribution from 25-100 nt.
“After polysome profiling and RNA sequencing, we retained 83,919 distinct 5′ UTRs spanning the entire length distribution from 25–100 nt.”
Quote in the paperSubstantial claim - Findingown data
Sequences with out-of-frame upstream start codons (uAUGs) or upstream open reading frames (uORFs) show decreased ribosome loading.
“Our data clearly show the expected decrease in ribosome loading for sequences with either out-of-frame upstream start codons (uAUGs) (Fig. 1c) or upstream open reading frames (uORFs) (Supplementary Fig. 2b)18,19.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [18] Morris, D. R. & Geballe, A. P. Upstream open reading frames as regulators of mRNA translation. Mol. Cell. Biol. 20, 8635–8642 (2000). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [19] Johnstone, T. G., Bazzini, A. A. & Giraldez, A. J. Upstream ORFs are prevalent translational repressors in vertebrates. EMBO J. 35, 706–723 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
- Findingown data
In our assay, the variant UTR of rs121908813 shows a −1.5 log2 difference in MRL compared to the wild type 5′ UTR sequence.
“In our assay, the variant UTR shows a −1.5 log2 difference in MRL compared to the wild type 5′ UTR sequence.”
Quote in the paperNot a substantial claim - Findingown data
Reevaluation of held-out sequences from the 'target MRL' library showed a dramatic improvement in comparison to the original model (r2 from 0.386 to 0.772).
“Reevaluation of held-out sequences from the ‘target MRL’ library showed a dramatic improvement in comparison to the original model (r2 from 0.386 to 0.772) (Fig. 3e and Supplementary Fig. 13a) as did the predicted loading of the step-wise evolved sequences (Fig. 3c red line and Supplementary Fig. 12a–d).”
Quote in the paperSubstantial claim - Findingown data
Optimus 5-Prime, trained only on the eGFP library, explained 77% and 78% of the variation in MRL for two independent polysome profiling experiments of an mCherry reporter library.
“we found that the model, although only trained on the eGFP library, still performed well, explaining 77% and 78% of the variation in MRL for two independent polysome profiling experiments of this new reporter library (Supplementary Fig. 5).”
Quote in the paperSubstantial claim - Findingown data
The most poorly translated sequence showed 15-fold less fluorescence than the best.
“Fluorescence and predicted MRL were highly correlated (r2: 0.87) and the most poorly translated sequence showed 15-fold less fluorescence than the best (Fig. 2e).”
Quote in the paperNot a substantial claim - Findingown data
CUG and GUG start codons can impact ribosome loading, especially when surrounded by strong sequence context.
“Still, we found that CUG and GUG start codons can impact ribosome loading, especially when surrounded by strong sequence context (Supplementary Figs. 3 and 4).”
Quote in the paperNot a substantial claim - Findingown data
Combining polysome profiling of a library of 280,000 randomized 5′ UTRs with deep learning built a predictive model that relates human 5′ UTR sequence to translation.
“Here, we combine polysome profiling of a library of 280,000 randomized 5′ UTRs with deep learning to build a predictive model that relates human 5′ UTR sequence to translation.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
- Findingown data
45 SNVs associated with human diseases substantially change ribosome loading.
“Finally, we provide evidence of 45 SNVs associated with human diseases that substantially change ribosome loading and thus may represent a molecular basis for disease.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
- Findingown data
Optimus 5-Prime MRL predictions correlated well with independently reported fluorescence levels for 77 5′ UTRs previously designed by Ferreira et al. (r2: 0.73-0.85).
“Our model’s MRL predictions correlated well with the independently reported fluorescence levels (r2: 0.73–0.85, Supplementary Fig. 9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Ferreira, J. P., Overton, K. W. & Wang, C. L. Tuning gene expression with synthetic upstream open reading frames. Proc. Natl Acad. Sci. USA 110, 11284–11289 (2013). source
Checked before — its earlier verdict is held back until a new check runs.
- Findingown data
The model predicts ribosome loading of 35,000 truncated human 5′ UTRs and 3,577 naturally occurring variants.
“We test 35,000 truncated human 5′ UTRs and 3,577 naturally occurring variants and show that the model predicts ribosome loading of these sequences.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
- Findingown data
The model can explain 76% of the change of variants with log2 differences greater than 0.5 or less than −0.5.
“Importantly, the model can explain 76% of the change of variants with log2 differences greater than 0.5 or less than −0.5 (Supplementary Fig. 14a).”
Quote in the paperSubstantial claim - Findingnone given
Using Optimus 5-Prime and a genetic algorithm, we were able to engineer new 5′ UTR sequences for targeted ribosome loading.
“Finally, using Optimus 5-Prime and a genetic algorithm, we were able to engineer new 5′ UTR sequences for targeted ribosome loading, enabling even more forward-looking applications in synthetic biology and precision medicine.”
Quote in the paperSubstantial claim - Findingown data
Optimus 5-Prime could explain 93% of MRL variation in the test set.
“After an exhaustive grid search to find optimal hyperparameters (Fig. 2a, Online Methods), Optimus 5-Prime could explain 93% of MRL variation in the test set (Fig. 2b).”
Quote in the paperSubstantial claim - Findingown data
For the step-wise evolved UTRs in the second set, predicted MRLs closely matched the trend of the observed MRL along the trajectory.
“For the step-wise evolved UTRs in the second set, predicted MRLs (green) closely matched the trend of the observed (blue) along the trajectory.”
Quote in the paperSubstantial claim - Findingown data
Position-specific k-mer (k = 1-6) linear models could at best explain 66% of the variation in the test set.
“By comparison, position-specific k-mer (k = 1–6) linear models could at best explain 66% of the variation in the test set (Supplementary Figs. 6 and 7, Supplementary Table 1).”
Quote in the paperSubstantial claim - Findingown data
The average number of sequencing reads per library member rapidly decreased with increasing UTR length.
“In fact, we found that the average number of sequencing reads per library member rapidly decreased with increasing UTR length, likely because of the decreasing yield of full-length sequences for longer 5′ UTRs (Supplementary Fig. 15b).”
Quote in the paperSubstantial claim - Findingreasoning
For sequences not containing uAUGs, the MRL slightly increased with length.
“Moreover, for sequences not containing uAUGs, the MRL slightly increased with length, likely because longer transcripts can accommodate more ribosomes (Supplementary Fig. 15a).”
Quote in the paperNot a substantial claim - Findingreasoning
Prediction accuracy for modified RNAs could be further improved by training the models directly on data from the modified RNAs.
“Prediction accuracy could be further improved by training the models directly on data from the modified RNAs (the same held-out library sequences were used in all test sets to ensure consistency).”
Quote in the paperNot a substantial claim - Findingown data
In both sets, the prediction from the model and the observed MRL eventually diverged as the model produced UTRs with very high predicted MRLs.
“While we created sequences with high ribosome loading (Supplementary Fig. 12e), in both sets the prediction from the model and the observed MRL eventually diverged as the model produced UTRs with very high predicted MRLs.”
Quote in the paperSubstantial claim - Findingown data
eGFP fluorescence and predicted MRL were highly correlated (r2: 0.87).
“Fluorescence and predicted MRL were highly correlated (r2: 0.87) and the most poorly translated sequence showed 15-fold less fluorescence than the best (Fig. 2e).”
Quote in the paperSubstantial claim - Findingown data
Of the 12,000 total UTRs evolved for targeted expression in the first set, the median MRL for targets 3 through 8 followed the expected trend from low to high with low variability within each group.
“Of the 12,000 total UTRs evolved for targeted expression in the first set, the median MRL for targets 3 through 8 followed the expected trend from low to high with low variability within each group.”
Quote in the paperNot a substantial claim - Findingown data
As observed with the 50 nt library, sequences containing uAUGs had a lower median MRL than similar length sequences not containing them.
“As observed with the 50 nt library, sequences containing uAUGs had a lower median MRL than similar length sequences not containing them.”
Quote in the paperNot a substantial claim - Findingown data
The same approach can be extended to chemically modified RNA.
“We show that the same approach can be extended to chemically modified RNA, an important feature for applications in mRNA therapeutics and synthetic biology.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
- Findingown data
Both sequences containing uAUGs and not containing them could span the full MRL range.
“Both sequences containing uAUGs and not containing them could span the full MRL range.”
Quote in the paperSubstantial claim - Findingown data
Mean ribosome load is more positively correlated with a UTR's predicted minimum free energy (MFE) for Ψ (r = 0.56) and m1Ψ (r = 0.58) than for U (r = 0.43).
“Concordantly, mean ribosome load is more positively correlated with a UTR’s predicted minimum free energy (MFE) for Ψ (r = 0.56) and m1Ψ (r = 0.58) than for U (r = 0.43) (Fig. 2i).”
Quote in the paperNot a substantial claim - Findingown data
Using the retrained model, the authors were able to explain 81% of the observed variation in MRL with the common and SNV 5′ UTR sequences.
“Using the retrained model, we were able to explain 81% of the observed variation in MRL with the common and SNV 5′ UTR sequences (Fig. 4a) showing that, despite training on random sequences, the model was able to learn the cis-regulatory rules of human 5′ UTR sequences that lay directly upstream of a coding sequence.”
Quote in the paperSubstantial claim - Findingown data
The analysis recapitulated the importance of a purine (A or G) at position −3 relative to AUG and a G at +4.
“This analysis recapitulated the importance of a purine (A or G) at position −3 relative to AUG and a G at +4 (Fig. 1e)10,23,24.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [10] Noderer, W. L. et al. Quantitative analysis of mammalian translation initiation sites by FACS-seq. Mol. Syst. Biol. 10, 748 (2014). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [23] Hinnebusch, A. G. The scanning mechanism of eukaryotic translation initiation. Annu. Rev. Biochem. 83, 779–812 (2014). source
- cites [24] Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283–292 (1986). source
- Findingown data
On average, CUG and GUG are used considerably less as alternative start codons compared to AUG.
“On average, we observed considerably lower use of CUG and GUG as alternative start codons compared to AUG (Fig. 1c and Supplementary Figs. 3 and 4) unlike other reports that show widespread usage of non-AUG start sites15,20,21, possibly because these alternative start codons are used more often under stress conditions22.”
Quote in the paperNot a substantial claim - Interpretationown data
Decreased expression of TMEM127 could explain the observed pathogenicity of rs121908813.
“TMEM127 acts as a tumor suppressor and decreased expression of it could explain the observed pathogenicity of this variant.”
Quote in the paperSubstantial claim- Rests on an assumption: TMEM127 acts as a tumor suppressor.
- Rests on an assumption: Changes in mean ribosome load (MRL) measured in the assay reflect changes in protein expression that can affect disease pathogenicity.
- Interpretationreasoning
The relatively lower predictive accuracy compared to direct variant effect prediction is a consequence of the increased noise due to comparing two measurements.
“The relatively lower predictive accuracy compared to direct variant effect prediction is a consequence of the increased noise due to comparing two measurements.”
Quote in the paperSubstantial claim - Interpretationown data
UTRs with more reads have higher resolution and more accurately reflect their mean ribosome load than low-read, noisier UTRs.
“UTRs with more reads have higher resolution and so more accurately reflect their mean ribosome load compared to low read, and thus noisier UTRs (Supplementary Fig. 15a–c).”
Quote in the paperNot a substantial claim - Interpretationown data
The large MRL difference suggests that rs867711777, labeled as uncertain in the ClinVar database, could be pathogenic.
“The large MRL difference suggests that this SNV, labeled as uncertain in the ClinVar database, could be pathogenic.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in mean ribosome load (MRL) measured in the assay reflect changes in protein expression that can affect disease pathogenicity.
- Interpretationown data
The 45 disease-associated SNVs that substantially change ribosome loading may represent a molecular basis for disease.
“Finally, we provide evidence of 45 SNVs associated with human diseases that substantially change ribosome loading and thus may represent a molecular basis for disease.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
- Interpretationreasoning
The 5′ UTR library with random sequence length 25 to 100 nt would increase the coverage of human 5′ UTRs to 29%.
“To this end, we first created a 5′ UTR library where the length of the random sequence upstream of the start codon ranged from 25 to 100 nt, which would increase the coverage of human 5′ UTRs to 29%.”
Quote in the paperSubstantial claim - Premisecitation
Variants within the 50 nt window directly adjacent to the start codon are under stronger negative selection than those further upstream.
“Intriguingly, variants within the 50 nt window directly adjacent to the start codon are under stronger negative selection than those further upstream16, providing another motivation to focus on this window.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Whiffin, N. et al. Characterising the loss-of-function impact of 5′ untranslated region variants in whole genome sequence data from 15,708 individuals. Preprint at https://www.biorxiv.org/content/10.1101/543504v1 (2019).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
Assessing model performance on endogenous transcripts is challenging due to confounding contributions of 3′ UTRs and coding sequence lengths.
“Assessing model performance on endogenous transcripts is challenging due to confounding contributions of 3′ UTRs and coding sequence lengths.”
Quote in the paperSubstantial claim - Interpretationnone given
A model-based approach can in principle be used to score the impact of any 5′ UTR variant on translation.
“In contrast, a model-based approach can in principle be used to score the impact of any 5′ UTR variant on translation.”
Quote in the paperSubstantial claim - Interpretationreasoning
The MRL increase with length for sequences not containing uAUGs is likely because longer transcripts can accommodate more ribosomes.
“Moreover, for sequences not containing uAUGs, the MRL slightly increased with length, likely because longer transcripts can accommodate more ribosomes (Supplementary Fig. 15a).”
Quote in the paperNot a substantial claim - Interpretationown data
The data and model enabled the quantitative assessment of secondary structure, uAUGs and uORFs, Kozak sequences, and other cis-regulatory sequence elements in the context of unmodified mRNA, Ψ, and m1Ψ-modified mRNA.
“The data and model enabled the quantitative assessment of secondary structure, uAUGs and uORFs, Kozak sequences, and other cis-regulatory sequence elements in the context of unmodified mRNA, Ψ, and m1Ψ-modified mRNA.”
Quote in the paperSubstantial claim - Interpretationown data
The decrease in accuracy of the model on the mCherry library is explained in part by differences between the eGFP and mCherry polysome profiling protocols.
“The decrease in accuracy is explained in part due to differences between the eGFP and mCherry polysome profiling protocols (Online Methods).”
Quote in the paperNot a substantial claim - Interpretationown data
The decrease in average reads with increasing UTR length is likely because of the decreasing yield of full-length sequences for longer 5′ UTRs.
“In fact, we found that the average number of sequencing reads per library member rapidly decreased with increasing UTR length, likely because of the decreasing yield of full-length sequences for longer 5′ UTRs (Supplementary Fig. 15b).”
Quote in the paperNot a substantial claim - Interpretationown data
Despite training on random sequences, the model was able to learn the cis-regulatory rules of human 5′ UTR sequences that lay directly upstream of a coding sequence.
“showing that, despite training on random sequences, the model was able to learn the cis-regulatory rules of human 5′ UTR sequences that lay directly upstream of a coding sequence.”
Quote in the paperSubstantial claim - Interpretationown data
The slight decrease in performance observed for longer 5′ UTRs is due to lower read coverage for longer sequences and concomitant decrease in the quality of the test set.
“The slight decrease in performance observed for longer 5′ UTRs is due to lower read coverage for longer sequences and concomitant decrease in the quality of the test set.”
Quote in the paperNot a substantial claim - Interpretationown data
Each TIS sequence can uniquely tune translation initiation to a fine degree.
“Ultimately, these data suggest that each TIS sequence can uniquely tune translation initiation to a fine degree.”
Quote in the paperSubstantial claim - Premisecitation
FACS- and growth-selection-based MPRAs require expression of a single library variant per cell that must be transcribed within the cell from a DNA template, making it difficult to distinguish between the effects of transcriptional and translational control.
“These techniques require the expression of a single library variant per cell that must be transcribed within the cell from a DNA template, making it difficult to distinguish between the effects of transcriptional and translational control.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [10] Noderer, W. L. et al. Quantitative analysis of mammalian translation initiation sites by FACS-seq. Mol. Syst. Biol. 10, 748 (2014). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [11] Kosuri, S. et al. Composability of regulatory sequences controlling transcription and translation in Escherichia coli. Proc. Natl Acad. Sci. USA 110, 14024–14029 (2013). source
- cites [12] Cuperus, J. T. et al. Deep learning of the regulatory grammar of yeast 5′ untranslated regions from 500,000 random sequences. Genome Res. 27, 2015–2024 (2017). source
Checked before — its earlier verdict is held back until a new check runs.
- Interpretationown data
The approach developed here is not limited to fixed-length UTRs and could be extended even beyond a 100 nt window by synthesizing correspondingly longer 5′ UTRs for model training.
“These results suggest that the approach we developed here is not limited to fixed-length UTRs and could be extended even beyond a 100 nt window by synthesizing correspondingly longer 5′ UTRs for model training.”
Quote in the paperNot a substantial claim - Premisecitation
Polysome profiling overcomes the limitation of single-variant-per-cell MPRAs by enabling single cells to translate tens to hundreds of in vitro transcribed (IVT) and transfected mRNA variants.
“Polysome profiling13 overcomes this limitation by enabling single cells to translate tens to hundreds of in vitro transcribed (IVT) and transfected mRNA variants.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] Zuccotti, P. & Modelska, A. in Post-Transcriptional Gene Regulation (ed. Dassi, E.) 59–69 (Humana Press, 2016). source
- Classified as probably not a substantial claim. 23
- May combine two claims. 21
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisecitationHow 5′ UTR sequences affect translation is only beginning to be understood.
“Genetic variants play a major role in phenotypic differences between individuals38 and how these sequences affect translation is only beginning to be understood39,40.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [39] Battle, A. et al. Impact of regulatory variation from RNA to protein. Science 347, 664–667 (2015). source
In the section labeled Abstract (page unavailable), the paper says that how genetic differences affect gene expression through translation has not been fully characterized. That supports the general point that understanding is incomplete, but the cited passage does not specifically address how 5′ UTR sequences affect translation. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [40] Cenik, C. et al. Integrative analysis of RNA, translation, and protein levels reveals distinct regulatory variation across humans. Genome Res. 25, 1610–1621 (2015). source
The Discussion (page unavailable) says the molecular mechanisms linking sequence to translation remain an interesting question and that less is known about positive regulation by upstream open reading frames. The Results show that 5′ UTR variants affect translation, but the paper does not characterize understanding of all 5′ UTR sequence effects as only beginning. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe two uridine analogs pseudouridine (Ψ) or 1-methyl-pseudouridine (m1Ψ) are widely used for mRNA therapeutics because they can increase mRNA stability and help modulate the host immune response.
“The two uridine analogs pseudouridine (Ψ) or 1-methyl-pseudouridine (m1Ψ) are widely used for mRNA therapeutics because they can increase mRNA stability and help modulate the host immune response31,32.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [31] Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008). source
The Introduction reports that pseudouridine (Ψ) suppresses RNA-mediated immune activation, and the Discussion describes increased biological stability of Ψ-modified mRNA as a likely contributor to enhanced translation. The paper does not address 1-methyl-pseudouridine (m1Ψ) or establish that both analogs are widely used in mRNA therapeutics. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [32] Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010). source
The Introduction and Discussion (page numbers unavailable) support pseudouridine’s role in reducing innate immune activation and its potential for therapeutic mRNA delivery. They do not establish that either analog increases mRNA stability, and the paper does not address 1-methyl-pseudouridine or establish that both analogs are widely used in therapeutics. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationMassively parallel reporter assays coupled with machine learning have proven useful in addressing similar voids by producing quantitative biological insight that would be difficult to achieve through traditional approaches.
“Massively parallel reporter assays (MPRAs) – methods that assess thousands to millions of sequence variants in a single experiment – coupled with machine learning have proven useful in addressing similar voids by producing quantitative biological insight that would be difficult to achieve through traditional approaches3–9.”
Quote in the paperSubstantial claim3 of 7 sources checked- cites [3] Angermueller, C., Pärnamaa, T., Parts, L. & Stegle, O. Deep learning for computational biology. Mol. Syst. Biol. 12, 878 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [4] Alipanahi, B., Delong, A., Weirauch, M. T. & Frey, B. J. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning. Nat. Biotechnol. 33, 831–838 (2015). source
- cites [5] Zhou, J. & Troyanskaya, O. G. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931–934 (2015). source
The Abstract describes DeepSEA, a deep-learning model that learns from large-scale chromatin-profiling data to predict effects of noncoding variants. This supports the broader point that machine learning can provide quantitative biological insight, but the paper does not describe coupling machine learning with massively parallel reporter assays. A search for “reporter” found no relevant passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [6] Kleftogiannis, D., Kalnis, P. & Bajic, V. B. DEEP: a general computational framework for predicting enhancers. Nucleic Acids Res. 43, e6 (2015). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [7] Liu, F., Li, H., Ren, C., Bo, X. & Shu, W. PEDLA: predicting enhancers with a deep learning-based algorithmic framework. Sci. Rep. 6, 28517 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [8] Kelley, D. R., Snoek, J. & Rinn, J. L. Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks. Genome Res. 26, 990–999 (2016). source
The Results section (‘In silico saturation mutagenesis’; page unavailable) describes parallel reporter assays as a way to measure the activity of many mutations, and presents Basset’s machine-learning predictions as an in silico approach to the same problem. It does not report coupling an MPRA with machine learning; Basset was trained on DNase-seq accessibility data, so the cited paper supports the broader point about quantitative insight but not the claimed combination. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [9] Zhao, W. et al. Massively parallel functional annotation of 3′ untranslated regions. Nat. Biotechnol. 32, 387–391 (2014). source
The main text (page unavailable) describes fast-UTR, a massively parallel reporter approach that quantified effects of 3′ UTR sequences and genetic variants. It does not report coupling the assay with machine learning; it says the resulting data could be useful for refining computational prediction methods. Thus the paper supports the assay’s quantitative value, but not the machine-learning part of the claim. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHuman 5′ UTR sequences vary in length from tens to thousands of nucleotides with a median length of 218 nt.
“Human 5′ UTR sequences vary in length from tens to thousands of nucleotides with a median length of 218 nt44,45.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [44] Mignone, F. et al. Untranslated regions of mRNAs. Genome Biol. 3, reviews0004.1 (2002). source
The Structural features of untranslated regions section (page not available in our copy) says that 5′ UTR lengths vary within a species from about a dozen to a few thousand nucleotides, supporting the claimed range. It does not give a median of 218 nt for human 5′ UTRs; it reports an average of 100–200 nt across diverse taxonomic classes instead. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [45] Leppek, K., Das, R. & Barna, M. Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell Biol. 19, 158–174 (2018). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataSeveral filters did not fall into the recognized motif categories and did not match previously described PWMs for RNA binding proteins, suggesting the possibility for previously undescribed regulatory interactions.
“Of note, several filters did not fall into either of these categories and also did not match previously described PWMs for RNA binding proteins (Tomtom29 and the Homo sapiens RBP database30), suggesting the possibility for previously undescribed regulatory interactions.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Tomtom29
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Homo sapiens RBP database30
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA model trained on data from another polysome profiling experiment performed similarly.
“A model trained on data from another polysome profiling experiment performed similarly (Supplementary Fig. 5a).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWe identified 2,308 additional SNVs that resulted from oligo synthesis errors, and 103 of them showed MRL changes greater than 0.5 or less than −0.5 in log2 scale.
“We also identified 2,308 additional SNVs that resulted from oligo synthesis errors, and found that 103 of them showed MRL changes greater than 0.5 or less than −0.5 in log2 scale (Supplementary Fig. 14b).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mCherry library contained approximately 500,000 sequences.
“The eGFP library contained approximately 750,000 unique sequences and the mCherry library contained approximately 500,000 sequences.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe ClinVar variant rs867711777 is found in the 5′ UTR of the CPOX gene and shows a log2 difference of −0.89.
“As an example, one of the ClinVar variants with sizeable differences in MRL, rs867711777, is found in the 5′ UTR of the CPOX gene and shows a log2 difference of −0.89.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTogether with a genetic algorithm, the model was used to engineer new 5′ UTRs that accurately direct specified levels of ribosome loading, providing the ability to tune sequences for optimal protein expression.
“Together with a genetic algorithm, we use the model to engineer new 5′ UTRs that accurately direct specified levels of ribosome loading, providing the ability to tune sequences for optimal protein expression.”
Quote in the paperSubstantial claim- Rests on an assumption: The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
- Rests on an assumption: The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
May combine two claims.
Findingown dataOptimus 5-Prime, the CNN trained on the data, explains up to 93% of mean ribosome load variation in the test set and up to 81% of variation for 38,789 truncated human UTRs.
“Optimus 5-Prime, the CNN trained on the data has notable performance, explaining up to 93% of mean ribosome load variation in the test set and up to 81% of variation for 38,789 truncated human UTRs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe eGFP library contained approximately 750,000 unique sequences.
“The eGFP library contained approximately 750,000 unique sequences and the mCherry library contained approximately 500,000 sequences.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUsing the expanded dataset, the retrained Optimus 5-Prime model showed increased accuracy with all sub-libraries and unchanged performance with random library sequences.
“Using this expanded dataset, we retrained the Optimus 5-Prime model in Figure 2, which showed increased accuracy with all sub-libraries and unchanged performance with random library sequences (Supplementary Fig. 13b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe variant rs376208311 lies in the 5′ UTR of the ribosomal subunit gene RPL5 and shows a −0.87 log2 difference in MRL.
“The variant rs376208311 lies in the 5′ UTR of the ribosomal subunit gene RPL5 and shows a −0.87 log2 difference in MRL.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAdding a third convolution layer and additional filters to each layer improved the performance of the 5′ UTR model used for evolving new sequences.
“sometime after training this first model we determined that adding a third convolution layer and additional filters to each layer showed improved performance.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataThe model performs nearly as well after randomly splitting the training (260,000) and test (20,000) sets as with the read-count-based split.
“However, the model performs nearly as well after randomly splitting the training (260,000) and test (20,000) sets (Supplementary Fig. 15d).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe majority of SNVs had little to no effect, but 45 had log2 differences greater than 0.5 or less than −0.5.
“The majority of SNVs had little to no effect, but 45 had log2 differences greater than 0.5 or less than −0.5 (Supplementary Table 4, Clinvar SUB4797518).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenNo sequences between the eGFP and mCherry library matched.
“No sequences between the eGFP and mCherry library matched.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe generalized Optimus 5-Prime model performed well on both the human (r2: 0.78) and random (r2: 0.84) sequences and for 5′ UTRs of any length (r2: 0.75-0.84).
“The generalized Optimus 5-Prime model performed well on both the human (r2: 0.78) and random (r2: 0.84) sequences (Supplementary Fig. 15c,d) and for 5′ UTRs of any length (Fig. 4e, r2: 0.75–0.84).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOverall, Optimus 5-Prime could explain 55% of the observed MRL change and accurately predicted the direction of change for 64% of the variants.
“Overall, Optimus 5-Prime could explain 55% of the observed MRL change (Fig. 4b) and accurately predicted the direction of change for 64% of the variants.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataVisualization of the filters in the first and second convolution layer revealed recognizable motifs including strong TIS sequences (e.g. ACCAUG), stop codons (TAA, TGA, TAG), uORFs, non-canonical start codons (CUG, GUG), and sequences composed of multiples of CG or AU likely involved in secondary structure formation.
“Visualization of the filters in the first and second convolution layer revealed recognizable motifs including strong TIS sequences (e.g. ACCAUG), stop codons (TAA, TGA, TAG), uORFs, non-canonical start codons (CUG, GUG), and sequences composed of multiples of CG or AU likely involved in secondary structure formation (Fig. 2f and Supplementary Fig. 10).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWe performed 10-fold cross-validation grid search to exhaustively test hyperparameter combinations.
“We performed 10-fold cross-validation grid search to exhaustively test hyperparameter combinations of convolution layers (2, 3), convolution filter lengths (8, 10, 12), number of convolution filters (40, 80, 120), number of nodes in the dense layer (40, 80, 120), dropout probability between all layers (0, 0.2, 0.4).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGenetic variants play a major role in phenotypic differences between individuals.
“Genetic variants play a major role in phenotypic differences between individuals38 and how these sequences affect translation is only beginning to be understood39,40.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Hernandez, R. D. et al. Singleton variants dominate the genetic architecture of human gene expression. Preprint https://doi.org/10.2139/ssrn.3151998 (2018). source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBoth RT primers have unique molecular indices (UMIs).
“Both RT primers have unique molecular indices (UMIs).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe SNV rs121908813 is implicated in familial pheochromocytoma, a condition characterized by tumors found in the neuroendocrine system that secrete high levels of catecholamines.
“Another SNV, rs121908813, is implicated in familial pheochromocytoma, a condition characterized by tumors found in the neuroendocrine system that secrete high levels of catecholamines43.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Qin, Y. et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat. Genet. 42, 229–233 (2010). source
Checked before — its earlier verdict is held back until a new check runs.
May combine two claims.
InterpretationreasoningThe model can be used to screen every possible SNV, insertion or deletion in the 100 bases upstream of the start codon and select those with the strongest impact on ribosome loading and thus the highest likelihood of being pathogenic.
“Of note, predictions are not limited to common variants or even those that have been previously described; instead the model can be used to screen every possible SNV, insertion or deletion in the 100 bases upstream of the start codon – there are millions in the human genome - and select those for further study that have the strongest impact on ribosome loading and thus the highest likelihood of be”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in mean ribosome load (MRL) measured in the assay reflect changes in protein expression that can affect disease pathogenicity.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenExisting approaches to this problem, such as quantitative trait locus (QTL) analysis and genome wide association studies (GWAS), are limited to common variants and cannot scale to the enormous number of rare 5′ UTR variants occurring in the human population.
“But existing approaches to this problem, such as quantitative trait locus (QTL) analysis and genome wide association studies (GWAS) are limited to common variants and cannot scale to the enormous number of rare 5′ UTR variants occurring in the human population.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPolysome profiling has been used extensively to measure translation of native RNA isoforms, but isolating the role of 5′ UTR regulation has been difficult due to differences in the size and sequence of the concomitant coding sequences and 3′ UTRs.
“Polysome profiling has been used extensively to measure translation of native RNA isoforms14,15 but isolating the role of 5′ UTR regulation has been difficult due to differences in the size and sequence of the concomitant coding sequences and 3′ UTRs.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [14] Floor, S. N. & Doudna, J. A. Tunable protein synthesis by transcript isoforms in human cells. elife 5, e10921 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [15] Wang, X., Hou, J., Quedenau, C. & Chen, W. Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals. Mol. Syst. Biol. 12, 875 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataTraining of the k-mer linear model involved regularization to limit overfitting and 5-fold cross validation.
“Training involved regularization to limit overfitting and 5-fold cross validation.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataOur model proved capable of predicting the effect of disease-relevant 5′ UTR variants on translation, even suggesting mechanisms of action.
“Our model also proved capable of predicting the effect of disease-relevant 5′ UTR variants on translation, even suggesting mechanisms of action.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenUTRs were removed if the CDS sequence did not match the intended sequence.
“UTRs were removed if the CDS sequence did not match the intended sequence.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenRelative reads were calculated within each fraction to normalize differences in total read counts between fractions.
“To normalize differences in total read counts between fractions, relative reads were calculated within each fraction.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDepletion of CPOX reduces heme biosynthesis and is the cause of hereditary coproporphyria (HCP).
“The depletion of CPOX reduces heme biosynthesis and is the cause of hereditary coproporphyria (HCP)41.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Wang, B. & Bissell, D. M. Hereditary Coproporphyria (University of Washington, 2012). .
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe model was trained over three epochs before overfitting occurred.
“The model was trained over three epochs before overfitting occurred.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataA small portion of the electroporation was plated and resulted in ~750,000 cfu.
“A small portion of the electroporation was plated and resulted in ~750,000 cfu and the rest was grown in liquid culture overnight (both under kanamycin selection).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataA second test set was created consisting of 7,600 human 5′ UTRs - 100 UTRs for every length from 25 to 100 nt.
“We also created a second test set consisting of 7,600 human 5′ UTRs – 100 UTRs for every length from 25 to 100 nt.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOne cause of Diamond-Blackfan anemia is disruption or downregulation of RPL5.
“One cause of the disease is a result of either the disruption or downregulation of RPL542.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Boria, I. et al. The ribosomal basis of Diamond–Blackfan anemia: mutation and database update. Hum. Mutat. 31, 1269–1279 (2010). source
Checked before — its earlier verdict is held back until a new check runs.
May combine two claims.
Interpretationown dataA majority of variants do not impact translation, resulting in a large cluster of variants for which the MRL change is close to zero where measurements are dominated by noise.
“Moreover, a majority of variants do not impact translation, resulting in a large cluster of variants for which the MRL change is close to zero where measurements are dominated by noise.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTranslation initiation and elongation is affected by RNA secondary structure that forms within 5′ UTRs and coding sequences, with strong structures showing the most negative effect on translation.
“Translation initiation and elongation is also affected by RNA secondary structure that forms within 5′ UTRs and coding sequences, with strong structures showing the most negative effect on translation17,25.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [17] Hinnebusch, A. G., Ivanov, I. P. & Sonenberg, N. Translational control by 5′-untranslated regions of eukaryotic mRNAs. Science 352, 1413–1416 (2016). source
Checked before — its earlier verdict is held back until a new check runs.
- cites [25] Kozak, M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl Acad. Sci. USA 83, 2850–2854 (1986). source
Checked before — its earlier verdict is held back until a new check runs.
Classified as probably not a substantial claim.
Study design and conductreasoningTo ensure that 5′ UTRs of every length would be represented equally, the 100 5′ UTRs with the deepest read coverage at every length (~10% of the library) were taken as the test set, rather than using the top 10% of the entire population.
“To ensure that 5′ UTRs of every length would be represented equally, we took the 100 5′ UTRs with the deepest read coverage at every length (~10% of the library) as the test set, rather than using the top 10% of the entire population.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The field lacks a means to accurately predict protein expression from 5′ UTR sequence alone.
“While many cis-regulatory elements within human 5′ UTRs have been characterized individually, the field still lacks a means to accurately predict protein expression from 5′ UTR sequence alone, limiting the ability to estimate the effects of genome-encoded variants and the ability to engineer 5′ UTRs for precise translation control.”
The paper relies on this without support.
The region surrounding the start codon (the translation initiation site or Kozak sequence) is a primary determinant of whether a ribosome will begin translation.
“The region surrounding the start codon, known as the translation initiation site (TIS) or the Kozak sequence, is a primary determinant of whether a ribosome will begin translation.”
The paper relies on this without support.
The first 50 bases upstream of the CDS contain the regulatory signals that mediate translation initiation beyond ribosomal recruitment to the 5′ cap.
“We initially focused on the first 50 bases upstream of the CDS to specifically investigate the regulatory signals that mediate the initiation of translation beyond ribosomal recruitment to the 5′ cap.”
The paper relies on this without support.
TMEM127 acts as a tumor suppressor.
“TMEM127 acts as a tumor suppressor and decreased expression of it could explain the observed pathogenicity of this variant.”
The paper relies on this without support.
The variant rs376208311 is associated with Diamond-Blackfan anemia (BDA).
“This variant is associated with Diamond-Blackfan anemia (BDA).”
The paper relies on this without support.
Changes in mean ribosome load (MRL) measured in the assay reflect changes in protein expression that can affect disease pathogenicity.
“select those for further study that have the strongest impact on ribosome loading and thus the highest likelihood of being pathogenic.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The authors of ref. [46] also demonstrated that MRL inversely correlates with minimal free energy values.
“It should be pointed out that the authors of ref. [46] also demonstrated that MRL inversely correlates with minimal free energy values.”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
The Results section (‘Evaluation of mRNA containing Ψ and m1Ψ’) reports a positive, not inverse, correlation between mean ribosome load and predicted minimum free energy for U, Ψ, and m1Ψ. The supplied passage does not give a page number. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredHigher GC content and highly negative folding minimal free energy (ΔG) of 5′UTRs correlate with inhibition of translation.
“In addition to greater length, the TPL sequence has a higher GC content and highly negative folding minimal free energy (ΔG), which correlates with inhibition of translation [4,7,45,46] (Table 1).”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
In Results, “MPRA design and validation” (page unavailable), the paper reports that strong RNA secondary structures have a negative effect on translation and that comparing 5′ UTR minimum free energy with ribosome load captured this repressive effect. It does not establish a separate correlation between higher GC content and translation inhibition; the TPL sequence measurements are the citing authors’ own observations. (LLM, conf=0.84)
Experimental — accuracy not yet measuredIn TPL, the presence of unique cis- and/or trans-regulatory elements that ensure efficient translation is indirectly confirmed by evidence obtained via assessment of predicted mean ribosomal loading (MRL) with the Optimus 5-Prime algorithm.
“In TPL, the presence of unique cis- and/or trans-regulatory elements that ensure efficient translation is indirectly confirmed by evidence obtained via assessment of predicted mean ribosomal loading (MRL) with the Optimus 5-Prime algorithm [46].”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
The Results section (“Modeling 5′ UTRs and ribosome loading”; page unavailable) establishes that Optimus 5-Prime predicts MRL from 5′ UTR sequence and that predicted MRL correlates with protein expression. The paper does not assess TPL or establish that TPL contains unique cis- or trans-regulatory elements; its model results cannot, by themselves, confirm their presence there. (LLM, conf=0.86)
Experimental — accuracy not yet measuredOn the basis of 280,000 different 5′UTR sequences, the authors of that paper demonstrated that MRL values range from 2 to 11.
“On the basis of 280,000 different 5′UTR sequences, the authors of that paper demonstrated that MRL values range from 2 to 11.”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
Online Methods (“Sequence Processing”) says the authors selected 280,000 distinct 5′ UTR sequences for the eGFP library and calculated mean ribosome load (MRL) for them. The Results (“Modeling 5′ UTRs and ribosome loading”) also identifies the 280,000-member library, but the passages found do not establish that its MRL values ranged from 2 to 11. (LLM, conf=0.86)
Experimental — accuracy not yet measuredUsing a new set of 5′ UTR synthetic sequences based on selection of synthetic 5′ UTRs with high ribosome loading improved mRNA translation.
“Here, we improved the mRNA translation by using a new set of 5′ UTR synthetic sequences based on the selection of synthetic 5′ UTRs with high ribosome loading.22”
From Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA (2021) · cites this paper as [22]
The predictive model (Optimus 5-Prime) was tested only for 5′UTR sequences up to 100 bp in length.
“It is worth noting that the predictive model in question was tested only for 5′UTR sequences up to 100 bp in length.”
From Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis (2024) · cites this paper as [37]
Optimus 5-Prime is a method for predicting MRL of a transcript through the use of convolutional neural networks.
“The latter is a method for predicting MRL of a transcript through the use of convolutional neural networks.”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
The Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin and the 3′ UTR AES-mtRNR1 combination.
“the Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin, which was identified as one of the top 20% 5′ UTRs in massive screening studies,10,11,13 and the 3′ UTR AES-mtRNR1 combination of two genes, AES (Amino Enhancer of Split) and mtRNR1 (12S mitochondrial RNA).12”
From Evaluation of synthetic mRNA with selected UTR sequences and alternative poly(A) tail, in vitro and in vivo (2025) · cites this paper as [11]
The Results (MPRA design and validation) and Online Methods (Design and Synthesis of varying Lengths 5′ UTR Sequences) describe large-scale screening of human 5′ UTRs, but the passages found do not identify α-globin’s UTR as being in the top 20% or discuss the Pfizer-BioNTech vaccine. Searches for globin, HBA1/HBA2, the top-20% ranking, and the vaccine found no passage establishing those points. The AES-mtRNR1 portion of the citing sentence is attached to a different citation. (LLM, conf=0.75)
Experimental — accuracy not yet measuredTPL as the 5′UTR had the highest MRL (7.7), whereas MRL of the other tested UTRs was within 5.7-6.7.
“TPL as the 5′UTR had the highest MRL (7.7), whereas MRL of the other tested UTRs was within 5.7–6.7.”
From Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA (2023) · cites this paper as [46]
The Results (MPRA design and validation; page unavailable) describe how mean ribosome load was measured, but do not identify TPL as a tested 5′ UTR. Searches of our copy for TPL, 7.7, and the 5.7–6.7 range found no passage reporting the claimed comparison. (LLM, conf=0.76)
Experimental — accuracy not yet measuredUTR performance can vary by cell type, so alternative UTR sequences optimized for the desired application and intended cell target may be used.
“However, because UTR performance can vary by cell type, alternative UTR sequences may be used that have been optimized for the desired application and intended cell target16–18.”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [16]
Sample et al. demonstrated that MRL values range from two to 11; among the highest MRLs, only in the range six-eight was there a high correlation (r2 = 0.77) between predicted and observed values.
“On the basis of 280,000 different 5′UTR sequences, the Sample et al. [37] study demonstrated that MRL values range from two to 11; however, among the highest MRLs, only in the range six–eight was there a high correlation (r2 = 0.77) between the predicted and observed values.”
From Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis (2024) · cites this paper as [37]
Cites
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889 · see citing works
TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems
Abadi, M., Agarwal, A., Barham, P., Brevdo, E., Chen, Z., Citro, C., Corrado, G. S., Davis, A., Dean, J., Devin, M., et al. (2016) · arXiv · doi:10.48550/arxiv.1603.04467 · Cited by 9,408 · see citing works
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741 · see citing works
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
Alipanahi, B., Delong, A., Weirauch, M. T., & Frey, B. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3300 · Cited by 2,873 · see citing works
The mechanism of eukaryotic translation initiation and principles of its regulation
Jackson, R. J., Hellen, C. U. T., & Pestova, T. V. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2838 · Cited by 2,759 · see citing works
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758 · see citing works
Predicting effects of noncoding variants with deep learning–based sequence model
Zhou, J., & Troyanskaya, O. G. (2015) · Nature Methods · doi:10.1038/nmeth.3547 · Cited by 2,338 · see citing works
Quantifying similarity between motifs
Gupta, S., Stamatoyannopoulos, J. A., Bailey, T. L., & Noble, W. S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r24 · Cited by 2,058 · see citing works
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930 · see citing works
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844 · see citing works
NUPACK: Analysis and design of nucleic acid systems
Zadeh, J. N., Steenberg, C. D., Bois, J. S., Wolfe, B. R., Pierce, M. B., Khan, A. R., Dirks, R. M., & Pierce, N. A. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21596 · Cited by 1,670 · see citing works
A compendium of RNA-binding motifs for decoding gene regulation
Ray, D., Kazan, H., Cook, K. B., Weirauch, M. T., Najafabadi, H. S., Li, X., Gueroussov, S., Albu, M., Zheng, H., Yang, A., et al. (2013) · Nature · doi:10.1038/nature12311 · Cited by 1,480 · see citing works
Deep learning for computational biology
Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156651 · Cited by 1,473 · see citing works
BioMart – biological queries made easy
Smedley, D. P., Haider, S. A., Ballester, B., Holland, R., London, D., Þórisson, G. Á., & Kasprzyk, A. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-22 · Cited by 1,119 · see citing works
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Hinnebusch, A. G., Ivanov, I. P., & Sonenberg, N. (2016) · Science · doi:10.1126/science.aad9868 · Cited by 1,079 · see citing works
Kelley, D. R., Snoek, J., & Rinn, J. L. (2016) · Genome Research · doi:10.1101/gr.200535.115 · Cited by 1,048 · see citing works
Untranslated regions of mRNAs.
(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987 · see citing works
Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
Leppek, K., Das, R., & Barna, M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.103 · Cited by 949 · see citing works
The Scanning Mechanism of Eukaryotic Translation Initiation
Hinnebusch, A. G. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035802 · Cited by 798 · see citing works
Upstream Open Reading Frames as Regulators of mRNA Translation
Morris, D. R., & Geballe, A. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8635-8642.2000 · Cited by 736 · see citing works
Self-citationInfluences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Kozak, M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2850 · Cited by 687 · see citing works
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682 · see citing works
Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution
Lee, S., Liu, B., Lee, S., Huang, S., Shen, B., & Qian, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207846109 · Cited by 595 · see citing works
Impact of regulatory variation from RNA to protein
Battle, A., Khan, Z., Wang, S. H., Mitrano, A., Ford, M. J., Pritchard, J. K., & Gilad, Y. (2015) · Science · doi:10.1126/science.1260793 · Cited by 471 · see citing works
Kosuri, S., Goodman, D. B., Cambray, G., Mutalik, V. K., Gao, Y., Arkin, A. P., Endy, D., & Church, G. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301301110 · Cited by 392 · see citing works
Translation from the 5′ untranslated region shapes the integrated stress response
Starck, S. R., Tsai, J. C., Chen, K., Shodiya, M., Wang, L., Yahiro, K., Martins‐Green, M. M., Shastri, N., & Walter, P. (2016) · Science · doi:10.1126/science.aad3867 · Cited by 390 · see citing works
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Qin, Y., Yao, L., King, E. E., Buddavarapu, K., Lenci, R. E., Chocron, E. S., Lechleiter, J. D., Sass, M., Aronin, N., Schiavi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.533 · Cited by 379 · see citing works
Upstream ORFs are prevalent translational repressors in vertebrates
Johnstone, T. G., Bazzini, A. A., & Giraldez, A. J. (2016) · The EMBO Journal · doi:10.15252/embj.201592759 · Cited by 346 · see citing works
Seo, S. W., Yang, J.-S., Kim, I., Yang, J., Min, B. E., Kim, S., & Jung, G. Y. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2012.10.006 · Cited by 300 · see citing works
Before It Gets Started: Regulating Translation at the 5′ UTR
Araujo, P. R., Yoon, K., Ko, D., Smith, A. D., Qiao, M., Suresh, U., Burns, S. C., & Penalva, L. O. F. (2012) · Comparative and Functional Genomics · doi:10.1155/2012/475731 · Cited by 267 · see citing works
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.040 · Cited by 267 · see citing works
Tunable protein synthesis by transcript isoforms in human cells
Floor, S. N., & Doudna, J. A. (2016) · eLife · doi:10.7554/elife.10921 · Cited by 265 · see citing works
The contribution of pseudouridine to stabilities and structure of RNAs
Kierzek, E., Malgowska, M., Lisowiec, J., Turner, D. H., Gdaniec, Z., & Kierzek, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1330 · Cited by 264 · see citing works
The ribosomal basis of diamond-blackfan anemia: mutation and database update
Boria, I., Garelli, E., Gazda, H. T., Aspesi, A., Quarello, P., Pavesi, E., Ferrante, D., Meerpohl, J. J., Kartal, M., Da Costa, L., et al. (2010) · Human Mutation · doi:10.1002/humu.21383 · Cited by 233 · see citing works
A Deep Neural Network for Predicting and Engineering Alternative Polyadenylation
Bogard, N., Linder, J., Rosenberg, A. B., & Seelig, G. (2019) · Cell · doi:10.1016/j.cell.2019.04.046 · Cited by 215 · see citing works
Self-citationCenik, C., Cenik, E. S., Byeon, G. W., Grubert, F., Candille, S. I., Spacek, D., Alsallakh, B., Tilgner, H., Araya, C. L., Tang, H., et al. (2015) · Genome Research · doi:10.1101/gr.193342.115 · Cited by 208 · see citing works
Cuperus, J. T., Groves, B., Kuchina, A., Rosenberg, A. B., Jojic, N., Fields, S., & Seelig, G. (2017) · Genome Research · doi:10.1101/gr.224964.117 · Cited by 205 · see citing works
Self-citationQuantitative analysis of mammalian translation initiation sites by FACS‐seq
Noderer, W. L., Flockhart, R. J., Bhaduri, A., Diaz de Arce, A. J., Zhang, J., Khavari, P. A., & Wang, C. L. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145136 · Cited by 178 · see citing works
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals
Whiffin, N., Karczewski, K. J., Zhang, X., Chothani, S. P., Smith, M. J., Evans, D. G., Roberts, A. M., Quaife, N. M., Schäfer, S., Rackham, O. J. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-10717-9 · Cited by 175 · see citing works
Editorial: Yeast synthetic biology: new tools to unlock cellular function
(2015) · FEMS Yeast Research · doi:10.1093/femsyr/fou003 · Cited by 164 · see citing works
Massively parallel functional annotation of 3′ untranslated regions
Zhao, W., Pollack, J. L., Blagev, D. P., Zaitlen, N., McManus, M. T., & Erle, D. J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2851 · Cited by 125 · see citing works
DEEP: a general computational framework for predicting enhancers
Kleftogiannis, D., Kalnis, P., & Bajic, V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1058 · Cited by 125 · see citing works
Tuning gene expression with synthetic upstream open reading frames
Ferreira, J. P., Overton, K. W., & Wang, C. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305590110 · Cited by 116 · see citing works
Recent applications of synthetic biology tools for yeast metabolic engineering
Jensen, M. K., & Keasling, J. D. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12185 · Cited by 103 · see citing works
PEDLA: predicting enhancers with a deep learning-based algorithmic framework
Liu, F., Li, H., Ren, C., Bo, X., & Shu, W. (2016) · Scientific Reports · doi:10.1038/srep28517 · Cited by 101 · see citing works
Bartender: a fast and accurate clustering algorithm to count barcode reads
Zhao, L. H., Liu, Z., Levy, S. F., & Wu, S. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx655 · Cited by 95 · see citing works
Wang, X., Hou, J., Quedenau, C., & Chen, W. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166941 · Cited by 90 · see citing works
Tangsombatvichit, P., Semkiv, M. V., Sibirny, A. А., Jensen, L. T., Ratanakhanokchai, K., & Soontorngun, N. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fou002 · Cited by 63 · see citing works
PreTIS: A Tool to Predict Non-canonical 5’ UTR Translational Initiation Sites in Human and Mouse
Reuter, K., Biehl, A., Laurena, K., & Helms, V. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005170 · Cited by 44 · see citing works
Studying the Translatome with Polysome Profiling
Zuccotti, P., & Modelska, A. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3067-8_4 · Cited by 20 · see citing works
Post-Transcriptional Gene Regulation
Dassi, E. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3067-8 · Cited by 19 · see citing works
Whiffin, N., Karczewski, K. J., Zhang, X., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/543504 · Cited by 12 · see citing works
Singleton Variants Dominate the Genetic Architecture of Human Gene Expression
Hernandez, R. D., Uricchio, L. H., Hartman, K., Ye, C., Dahl, A., & Zaitlen, N. (2018) · doi:10.2139/ssrn.3151998 · Cited by 6 · see citing works
Predicting the Impact of cis-Regulatory Variation on Alternative Polyadenylation
Bogard, N., Linder, J., Rosenberg, A. B., & Seelig, G. (2018) · doi:10.1101/300061 · Cited by 4
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 801 · see citing works
Unlocking the promise of mRNA therapeutics
Rohner, E., Yang, R., Foo, K. S., Goedel, A., & Chien, K. R. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01491-z · Cited by 612 · see citing works
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works
Recent advances in mRNA vaccine technology
Pardi, N., Hogan, M. J., & Weissman, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.008 · Cited by 512 · see citing works
The landscape of mRNA nanomedicine
Huang, X., Kong, N., Zhang, X., Cao, Y., Langer, R., & Tao, W. (2022) · Nature Medicine · doi:10.1038/s41591-022-02061-1 · Cited by 511 · see citing works
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines
Nance, K. D., & Meier, J. L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00197 · Cited by 466 · see citing works
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics
Leppek, K., Byeon, G. W., Kladwang, W., Wayment-Steele, H. K., Kerr, C. H., Xu, A. F., Kim, D. S., Topkar, V. V., Choe, C., Rothschild, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28776-w · Cited by 399 · see citing works
Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics
Leppek, K., Byeon, G. W., Kladwang, W., Wayment-Steele, H. K., Kerr, C. H., Xu, A. F., Kim, D. S., Topkar, V. V., Choe, C., Rothschild, D., et al. (2021) · doi:10.1101/2021.03.29.437587 · Cited by 399 · see citing works
mRNA therapeutics in cancer immunotherapy
Beck, J. D., Reidenbach, D., Salomon, N., Sahin, U., Türeci, Ö., Vormehr, M., & Kranz, L. M. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01348-0 · Cited by 385 · see citing works
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Linares-Fernández, S., Lacroix, C., Exposito, J.-Y., & Verrier, B. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.002 · Cited by 376 · see citing works
Nucleic acid delivery for therapeutic applications
Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 339 · see citing works
mRNA vaccines for COVID-19: what, why and how
Park, J. W., Lagniton, P. N. P., Liu, Y., & Xu, R.-H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59233 · Cited by 321 · see citing works
Leveraging artificial intelligence in the fight against infectious diseases
Wong, F. J., de la Fuente‐Núñez, C., & Collins, J. J. (2023) · Science · doi:10.1126/science.adh1114 · Cited by 320 · see citing works
Recommendations for clinical interpretation of variants found in non-coding regions of the genome
Ellingford, J. M., Ahn, J. W., Bagnall, R. D., Baralle, D., Barton, S., Campbell, C., Downes, K., Ellard, S., Duff‐Farrier, C. R. A., FitzPatrick, D. R., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01073-3 · Cited by 257 · see citing works
Esposito, D., Weile, J., Shendure, J., Starita, L. M., Papenfuss, A. T., Roth, F. P., Fowler, D. M., & Rubin, A. F. (2019) · Genome biology · doi:10.1186/s13059-019-1845-6 · Cited by 248 · see citing works
Decoding mRNA translatability and stability from the 5′ UTR
Jia, L., Mao, Y., Ji, Q., Dersh, D., Yewdell, J. W., & Qian, S.-B. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0465-x · Cited by 248 · see citing works
Chen, J., Hu, Z., Sun, S., Tan, Q., Wang, Y., Yu, Q., Zong, L., Hong, L., Xiao, J., Shen, T., et al. (2022) · doi:10.1101/2022.08.06.503062 · Cited by 247 · see citing works
Melamed, J. R., Yerneni, S. S., Arral, M. L., LoPresti, S. T., Chaudhary, N., Sehrawat, A., Muramatsu, H., Alameh, M., Pardi, N., Weissman, D., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade1444 · Cited by 215 · see citing works
A Deep Neural Network for Predicting and Engineering Alternative Polyadenylation
Bogard, N., Linder, J., Rosenberg, A. B., & Seelig, G. (2019) · Cell · doi:10.1016/j.cell.2019.04.046 · Cited by 215 · see citing works
Self-citationChemically Modified Platforms for Better RNA Therapeutics
Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00611 · Cited by 184 · see citing works
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals
Whiffin, N., Karczewski, K. J., Zhang, X., Chothani, S. P., Smith, M. J., Evans, D. G., Roberts, A. M., Quaife, N. M., Schäfer, S., Rackham, O. J. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-10717-9 · Cited by 175 · see citing works
Griesemer, D. S., Xue, J. R., Reilly, S. K., Ulirsch, J. C., Kukreja, K., Davis, J. R., Kanai, M., Yang, D. K., Butts, J. C., Guney, M. H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.025 · Cited by 173 · see citing works
Goshisht, M. K. (2024) · ACS Omega · doi:10.1021/acsomega.3c05913 · Cited by 169 · see citing works
High-throughput 5’ UTR engineering for enhanced protein production in non-viral gene therapies
Cao, J., Novoa, E. M., Zhang, Z., Chen, W. C. W., Liu, D., Choi, G. C. G., Wong, A. S. L., Wehrspaun, C., Kellis, M., & Lu, T. K. (2021) · Nature Communications · doi:10.1038/s41467-021-24436-7 · Cited by 159 · see citing works
Human-specific genetics: new tools to explore the molecular and cellular basis of human evolution
Pollen, A. A., Kilik, U., Lowe, C. B., & Camp, J. G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00568-4 · Cited by 157 · see citing works
The genetic and biochemical determinants of mRNA degradation rates in mammals
Agarwal, V., & Kelley, D. R. (2022) · Genome Biology · doi:10.1186/s13059-022-02811-x · Cited by 155 · see citing works
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 153 · see citing works
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., & Dong, Y. (2020) · Advanced Materials · doi:10.1002/adma.202004452 · Cited by 152 · see citing works
RiNALMo: general-purpose RNA language models can generalize well on structure prediction tasks
Penić, R. J., Vlašić, T., Huber, R. G., Wan, Y., & Šikić, M. (2025) · Nature Communications · doi:10.1038/s41467-025-60872-5 · Cited by 146 · see citing works
Model-driven generation of artificial yeast promoters
Kotopka, B. J., & Smolke, C. D. (2020) · Nature Communications · doi:10.1038/s41467-020-15977-4 · Cited by 143 · see citing works
A 5′ UTR language model for decoding untranslated regions of mRNA and function predictions
Chu, Y., Yu, D., Li, Y., Huang, K., Shen, Y., Cong, L., Zhang, J. Y., & Wang, M. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00823-9 · Cited by 143 · see citing works
Machine-guided design of cell-type-targeting cis-regulatory elements
Gosai, S. J., Castro, R. I., Fuentes, N., Butts, J. C., Mouri, K., Alasoadura, M., Kales, S., Nguyen, T. T. L., Noche, R. R., Rao, A. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08070-z · Cited by 142 · see citing works
The Untranslated Regions of mRNAs in Cancer
Schuster, S. L., & Hsieh, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.011 · Cited by 138 · see citing works
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Rijkers, G. T., Weterings, N., Obregón‐Henao, A., Dutt, T., Dutt, T. S., van Overveld, F. J., & Henao-Tamayo, M. I. (2021) · Vaccines · doi:10.3390/vaccines9080848 · Cited by 134 · see citing works
Direct in vivo CAR T cell engineering
Short, L., Holt, R. A., Cullis, P. R., & Evgin, L. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.03.004 · Cited by 134 · see citing works
Singh, S., Sharma, P. C., Pal, N., Sarma, D. K., Tiwari, R. R., & Kumar, M. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00625 · Cited by 120 · see citing works
Machine Learning for Designing Next-Generation mRNA Therapeutics
Castillo-Hair, S. M., & Seelig, G. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00621 · Cited by 119 · see citing works
Self-citationNon-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
Vlatkovic, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050530 · Cited by 112 · see citing works
Sapkota, D., Lake, A. M., Yang, W., Yang, C., Wesseling, H., Guise, A. J., Uncu, C., Dalal, J. S., Kraft, A. W., Lee, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.077 · Cited by 111 · see citing works
Recent advances in nanoparticulate RNA delivery systems
Witten, J. J., Hu, Y., Langer, R., & Anderson, D. G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307798120 · Cited by 108 · see citing works
Hold out the genome: a roadmap to solving the cis-regulatory code
de Boer, C. G., & Taipale, J. (2024) · Nature · doi:10.1038/s41586-023-06661-w · Cited by 107 · see citing works
Linder, J., Bogard, N., Rosenberg, A. B., & Seelig, G. (2020) · Cell Systems · doi:10.1016/j.cels.2020.05.007 · Cited by 107 · see citing works
Self-citationHeterogeneity in mRNA Translation
Sonneveld, S., Verhagen, B. M. P., & Tanenbaum, M. E. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.04.008 · Cited by 104 · see citing works
Controlling gene expression with deep generative design of regulatory DNA
Zrimec, J., Fu, X., Muhammad, A. S., Skrekas, C., Jauniškis, V., Speicher, N. K., Börlin, C. S., Verendel, V., Chehreghani, M. H., Dubhashi, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32818-8 · Cited by 101 · see citing works
Sato, K., & Hamada, M. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad186 · Cited by 101 · see citing works
Determinants of genome-wide distribution and evolution of uORFs in eukaryotes
Zhang, H., Wang, Y., Wu, X., Tang, X., Wu, C., & Lü, J. (2021) · Nature Communications · doi:10.1038/s41467-021-21394-y · Cited by 100 · see citing works
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Kang, D. D., Li, H., & Dong, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114961 · Cited by 100 · see citing works
Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning
Castillo-Hair, S., Fedak, S., Wang, B., Linder, J., Havens, K., Certo, M., & Seelig, G. (2024) · Nature Communications · doi:10.1038/s41467-024-49508-2 · Cited by 98 · see citing works
Self-citationRNA chemistry and therapeutics
Wang, S., Weissman, D., & Dong, Y. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01237-x · Cited by 98 · see citing works
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
Bian, X., Zhou, L., Luo, Z., Liu, G., Hang, Z., Li, H., Li, F., & Wen, Y. (2025) · ACS Nano · doi:10.1021/acsnano.4c11858 · Cited by 97 · see citing works
Characteristics of seismic activity of the Upper Silesian Coal Basin in Poland
Stec, K. (2006) · Geophysical Journal International · doi:10.1111/j.1365-246x.2006.03227.x · Cited by 96 · see citing works
Recent progress in mRNA cancer vaccines
Yao, R., Xie, C., & Xia, X. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2307187 · Cited by 89 · see citing works
Eliciting antitumor immunity via therapeutic cancer vaccines
Peng, K., Zhao, X., Fu, Y., & Liang, Y. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01316-4 · Cited by 89 · see citing works
Movva, R., Greenside, P., Marinov, G. K., Nair, S., Shrikumar, A., & Kundaje, A. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218073 · Cited by 87 · see citing works
Application of deep learning in genomics
Liu, J., Li, J., Wang, H., & Yan, J. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1804-5 · Cited by 86 · see citing works
Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype
Pascolo, S. (2021) · Viruses · doi:10.3390/v13020270 · Cited by 86 · see citing works
Ding, K., Chin, M., Zhao, Y., Huang, W., Mai, B. K., Wang, H., Liu, P., Yang, Y., & Luo, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-50698-y · Cited by 86 · see citing works
mRNA ageing shapes the Cap2 methylome in mammalian mRNA
Despic, V., & Jaffrey, S. R. (2023) · Nature · doi:10.1038/s41586-022-05668-z · Cited by 85 · see citing works
mRNA vaccine sequence and structure design and optimization: Advances and challenges
Jin, L., Zhou, Y., Zhang, S., & Chen, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108015 · Cited by 85 · see citing works
Deep generative models design mRNA sequences with enhanced translational capacity and stability
Zhang, H., Liu, H., Xu, Y., Huang, H., Liu, Y., Wang, J., Qin, Y., Wang, H., Ma, L., Xun, Z., et al. (2025) · Science · doi:10.1126/science.adr8470 · Cited by 84 · see citing works
Scalable Functional Assays for the Interpretation of Human Genetic Variation
Tabet, D. R., Parikh, V. N., Mali, P., Roth, F. P., & Claussnitzer, M. (2022) · Annual Review of Genetics · doi:10.1146/annurev-genet-072920-032107 · Cited by 83 · see citing works
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Kwon, S., Kwon, M., Im, S., Lee, K., & Lee, H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01381-7 · Cited by 81 · see citing works
Lim, S., Khoo, R., Juang, Y.-C., Gopal, P., Zhang, H., Yeo, C., Peh, K. M., Teo, J., Ng, S., Henry, B., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01337 · Cited by 80 · see citing works
iRQC, a surveillance pathway for 40S ribosomal quality control during mRNA translation initiation
Garshott, D. M., An, H., Sundaramoorthy, E., Leonard, M., Vicary, A. C., Harper, J. W., & Bennett, E. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109642 · Cited by 78 · see citing works
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
İmani, S., Li, X., Chen, K., Maghsoudloo, M., Kaboli, P. J., Hashemi, M., Khoushab, S., & Li, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1501010 · Cited by 78 · see citing works
Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data
Zhou, Y., Fujikura, K., Mkrtchian, S., & Lauschke, V. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01437 · Cited by 76 · see citing works
mRNA therapeutics: New vaccination and beyond
Wei, H. Y., Zheng, L., & Wang, Z. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.022 · Cited by 74 · see citing works
Fast activation maximization for molecular sequence design
Linder, J., & Seelig, G. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04437-5 · Cited by 72 · see citing works
Self-citationLim, Y., Arora, S., Schuster, S. L., Corey, L., Fitzgibbon, M., Wladyka, C. L., Wu, X., Coleman, I. M., Delrow, J. J., Corey, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24445-6 · Cited by 69 · see citing works
Accuracy and data efficiency in deep learning models of protein expression
Nikolados, E.-M., Wongprommoon, A., Aodha, O. M., Cambray, G., & Oyarzún, D. A. (2022) · Nature Communications · doi:10.1038/s41467-022-34902-5 · Cited by 69 · see citing works
Wright, C. F., Quaife, N. M., Ramos-Hernández, L., Danecek, P., Ferla, M. P., Samocha, K. E., Kaplanis, J., Gardner, E. J., Eberhardt, R. Y., Chao, K. R., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.025 · Cited by 68 · see citing works
Bicknell, A. A., Reid, D. W., Licata, M. C., Jones, A. K., Cheng, Y. M., Li, M., Hsiao, C. J., Pepin, C. S., Metkar, M., Levdansky, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114098 · Cited by 68 · see citing works
Self-citationSiegel, D. A., Tonquèze, O. L., Biton, A., Zaitlen, N., & Erle, D. J. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab404 · Cited by 66 · see citing works
Höllerer, S., Meng-Papaxanthos, L., Gumpinger, A., Fischer, K., Beisel, C., Borgwardt, K. M., Benenson, Y., & Jeschek, M. (2020) · Nature Communications · doi:10.1038/s41467-020-17222-4 · Cited by 65 · see citing works
mRNA-Based Therapeutics in Cancer Treatment
Sun, H., Zhang, Y., Wang, G., Yang, W., & Xu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020622 · Cited by 63 · see citing works
Big data and deep learning for RNA biology
Hwang, H., Jeon, H., Yeo, N., & Baek, D. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01243-w · Cited by 63 · see citing works
Linares-Fernández, S., Moreno, J., Lambert, E., Mercier-Gouy, P., Vachez, L., Verrier, B., & Exposito, J.-Y. (2021) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2021.10.007 · Cited by 62 · see citing works
Peña-Martínez, E. G., & Rodríguez‐Martínez, J. A. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1601004 · Cited by 61 · see citing works
Direct analysis of ribosome targeting illuminates thousand-fold regulation of translation initiation
Niederer, R. O., Rojas-Durán, M. F., Zinshteyn, B., & Gilbert, W. V. (2022) · Cell Systems · doi:10.1016/j.cels.2021.12.002 · Cited by 60 · see citing works
UNI-RNA: UNIVERSAL PRE-TRAINED MODELS REVOLUTIONIZE RNA RESEARCHPreprint
Wang, X., Gu, R., Chen, Z., Li, Y., Ji, X.-H., Ke, G., & Wen, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.11.548588 · Cited by 60 · see citing works
Predicting mean ribosome load for 5’UTR of any length using deep learning
Karollus, A., Avsec, Ž., & Gagneur, J. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1008982 · Cited by 57 · see citing works
Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
Huff, A. L., Jaffee, E. M., & Zaidi, N. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156211 · Cited by 56 · see citing works
ERNIE-RNA: an RNA language model with structure-enhanced representations
Yin, W., Zhang, Z., Zhang, S., He, L., Zhang, R., Jiang, R., Liu, G., Wang, J., Zhang, X., Qin, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64972-0 · Cited by 55 · see citing works
Findlay, G. M. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab219 · Cited by 55 · see citing works
Integrated mRNA sequence optimization using deep learning
Gong, H., Wen, J., Luo, R., Feng, Y., Guo, J., Fu, H., & Zhou, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad001 · Cited by 53 · see citing works
Predicting the translation efficiency of messenger RNA in mammalian cells
Zheng, D., Persyn, L., Wang, J., Liu, Y., Ulloa-Montoya, F., Cenik, C., & Agarwal, V. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02712-x · Cited by 52 · see citing works
pegIT - a web-based design tool for prime editing
Anderson, M. V., Haldrup, J., Thomsen, E. A., Wolff, J. H., & Mikkelsen, J. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab427 · Cited by 52 · see citing works
Therapeutic mRNA Engineering from Head to Tail
Jia, L., & Qian, S. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00541 · Cited by 51 · see citing works
Massively parallel identification of mRNA localization elements in primary cortical neurons
Mendonsa, S., von Kügelgen, N., Dantsuji, S., Ron, M., Breimann, L., Baranovskii, A., Loedige, I., Kirchner, M., Fischer, M., Zerna, N., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01243-x · Cited by 51 · see citing works
Model-based reinforcement learning for biological sequence design
Angermueller, C., Dohan, D., Belanger, D., Deshpande, R., Murphy, K. J., & Colwell, L. J. (2020) · International Conference on Learning Representations · Cited by 51 · see citing works
Advances in the design and delivery of RNA vaccines for infectious diseases
Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115419 · Cited by 50 · see citing works
Exogenous RNA surveillance by proton-sensing TRIM25
Kim, M., Pyo, Y., Hyun, S., Jeong, M., Choi, Y., & Kim, V. N. (2025) · Science · doi:10.1126/science.ads4539 · Cited by 49 · see citing works
An Update on mRNA-Based Viral Vaccines
Jeeva, S., Kim, K., Shin, C. H., Wang, B., & Kang, S. (2021) · Vaccines · doi:10.3390/vaccines9090965 · Cited by 49 · see citing works
Self-citationDeciphering the impact of genetic variation on human polyadenylation using APARENT2
Linder, J., Koplik, S. E., Kundaje, A., & Seelig, G. (2022) · Genome Biology · doi:10.1186/s13059-022-02799-4 · Cited by 49 · see citing works
Self-citationComputational design of mRNA vaccines
Kim, Y.-A., Mousavi, K., Yazdi, A. K., Zwierzyna, M., Cardinali, M., Fox, D. M., Peel, T., Coller, J., Aggarwal, K., & Maruggi, G. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.07.024 · Cited by 47 · see citing works
Tang, X., Huo, M., Chen, Y., Huang, H., Qin, S., Luo, J., Qin, Z., Jiang, X., Liu, Y., Duan, X., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.003 · Cited by 47 · see citing works
Polyplex designs for improving the stability and safety of RNA therapeutics
Uchida, S., Lau, C. Y. J., Oba, M., & Miyata, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114972 · Cited by 46 · see citing works
Therapeutic synthetic and natural materials for immunoengineering
Slezak, A., Chang, K., Hossainy, S., Mansurov, A., Rowan, S. J., Hubbell, J. A., & Guler, M. O. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00805c · Cited by 44 · see citing works
Learning the Regulatory Code of Gene Expression
Zrimec, J., Buric, F., Kokina, M., García, V., & Zelezniak, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.673363 · Cited by 43 · see citing works
- Authors
- Sample, P. J., Wang, B., Reid, D. W., Presnyak, V., McFadyen, I. J., Morris, D. R., & Seelig, G.
- Affiliations
- University of Washington (US)
- Moderna Therapeutics (United States) (US)
- Corresponding author
- Seelig, Georg
- Venue
- Nature Biotechnology
- Published
- 2019-07
- Volume
- 37
- Issue
- 7
- Pages
- 803-809
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7100133
- OpenAlex
- W2955231772
- Cited by
- 442
- References
- 52
- Citations by year
- 2026: 71 · 2025: 92 · 2024: 96 · 2023: 58 · 2022: 41 · 2021: 47 · 2020: 21 · 2019: 14 · 2018: 1
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01CA207029)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- 5' untranslated region, translation initiation, ribosome loading, cis-regulatory sequences, variant effect prediction, single nucleotide variants, RNA modification, mRNA therapeutics, synthetic biology, deep learning, genetic algorithm, sequence design, polysome profiling, disease-associated variants
- MeSH terms
- Base Sequence, Gene Expression Regulation, Humans, Models, Genetic, Pseudouridine, Ribosomes, RNA, Messenger, Protein Biosynthesis, Reproducibility of Results, 5' Untranslated Regions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-05.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review